Quell Therapeutics and AstraZeneca Advance CAR-Treg Therapy for Type 1 Diabetes

AbbVie’s ELAHERE® Approved in the EU for Platinum-Resistant Ovarian Cancer

AstraZeneca’s Tagrisso Recommended for Approval in EU for Unresectable EGFR-Mutated NSCLC

Foundation Medicine Receives FDA Approval for FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® in NSCLC

Exact Sciences Partners with Carlos Ponce to Boost Colorectal Cancer Awareness in the Hispanic Community

Merck Receives Positive CHMP Opinion for KEYTRUDA® in Combination Therapy for First-Line Treatment of Non-Epithelioid Mesothelioma

Australia Launches Genomics Australia to Lead Advances in Genomic Medicine

Sidra Medicine Unveils Masterclasses Ahead of PMFG 2024 Summit

FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

CHMP Recommends Approval of Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

ADDF Invests $1.18M to Standardize p-tau217 Blood Tests for Alzheimer’s Diagnosis

GSK Reports Positive Interim Results for DREAMM-7 Trial of Blenrep in Multiple Myeloma

Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Home
/
update
/
details

PathPresenter and Paige Partner to Drive Adoption of AI-Powered Digital Pathology and Image Management Workflows

NextEdge Admin

17 Oct 2024

2 min 25 sec

Paige,AI technology,digital pathology workflows

PathPresenter, a leading enterprise pathology workflow platform known for its secure, scalable, and multi-tenant infrastructure, has announced a partnership with Paige, a pioneer in next-generation AI technology for healthcare. This collaboration aims to transform digital pathology workflows by integrating Paige’s advanced diagnostic AI tools directly into PathPresenter's platform, creating a seamless experience for hospitals and laboratories worldwide.

The joint solution will simplify AI adoption, enhancing efficiency and setting new benchmarks in digital pathology management. Pathologists will gain access to cutting-edge tools that streamline workflows and support more accurate diagnoses. This partnership combines PathPresenter’s comprehensive image management system with Paige’s innovative AI, which achieved the first FDA approval for a pathology AI application and continues to push boundaries with generative AI capabilities.

The collaboration will officially launch at the upcoming **Pathology Visions 2024** conference, where both companies will host an exclusive preconference workshop on November 3rd at the Hyatt Regency in Orlando, Florida. The workshop, titled **"Lessons from the Frontlines: Navigating the Integration of LIS, IMS, and AI in Pathology,"** will feature insights from a breakthrough project developed for Memorial Sloan Kettering Cancer Center (MSKCC).

"We're excited to integrate Paige's AI into PathPresenter, elevating sign-out processes and enhancing educational and research applications," said Dr. Rajendra Singh, founder of PathPresenter.

Peter Hamilton, General Manager of Diagnostics at Paige, added, "Our partnership with PathPresenter brings our AI solutions to more hospitals and labs, advancing our mission to support cancer care through open collaboration and industry-wide innovation."